Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers


1. 2521285-05-0
2. 2a7vpm5rwh
3. Refchem:1098492
4. Bay-2927088
5. Bay2927088
6. Sevabertinib (usan)
7. Bay 2927088
8. Sevabertinib [usan]
9. Sevabertinib [inn]
10. Orb2695587
11. Chembl6068074
12. Schembl22588603
13. Gtpl13491
14. Yqf2592
15. Ex-a12844
16. Nsc857380
17. Example 2 [wo2020216781]
18. Nsc-857380
19. (s)-2-(3-((1,4-dioxan-2-yl)methoxy)pyridin-4-yl)-3-((3-chloro-2-methoxyphenyl)amino)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
20. Sy458337
21. D13098
22. H50182
23. (s)-2-[3-[(1,4-dioxan-2-yl)methoxy]-4-pyridyl]-3-[(3-chloro-2-methoxyphenyl)amino]-6,7-dihydro-1h-pyrrolo[3,2-c]pyridin-4(5h)-one
24. 3-(3-chloro-2-methoxyanilino)-2-(3-{[(2s)-1,4-dioxan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
25. 3-(3-chloro-2-methoxyanilino)-2-[3-[[(2s)-1,4-dioxan-2-yl]methoxy]pyridin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one
26. 3-[(3-chloro-2-methoxyphenyl)amino]-2-(3-{[(2s)-1,4-dioxan-2-yl]methoxy}pyridin-4-yl)-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
27. 3-[(3-chloro-2-methoxyphenyl)amino]-2-[3-[(2s)-1,4-dioxan-2-yl Methoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
28. 4h-pyrrolo[3,2-c]pyridin-4-one, 3-[(3-chloro-2-methoxyphenyl)amino]-2-[3-[(2s)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-
| Molecular Weight | 484.9 g/mol |
|---|---|
| Molecular Formula | C24H25ClN4O5 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 107 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 690 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Sevabertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sevabertinib manufacturer or Sevabertinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sevabertinib manufacturer or Sevabertinib supplier.
A Sevabertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sevabertinib, including repackagers and relabelers. The FDA regulates Sevabertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sevabertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sevabertinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Sevabertinib supplier is an individual or a company that provides Sevabertinib active pharmaceutical ingredient (API) or Sevabertinib finished formulations upon request. The Sevabertinib suppliers may include Sevabertinib API manufacturers, exporters, distributors and traders.
click here to find a list of Sevabertinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Sevabertinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sevabertinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sevabertinib GMP manufacturer or Sevabertinib GMP API supplier for your needs.
A Sevabertinib CoA (Certificate of Analysis) is a formal document that attests to Sevabertinib's compliance with Sevabertinib specifications and serves as a tool for batch-level quality control.
Sevabertinib CoA mostly includes findings from lab analyses of a specific batch. For each Sevabertinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sevabertinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Sevabertinib EP), Sevabertinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sevabertinib USP).